High Katherine A Insider Trades

Insider Trading History

Track insider trading activity for High Katherine A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Incyte
Incyte INCY
Director
Holding Value $1.56M 14,983 shares
Last Trade
Jun 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$780k 7,753 shares
$100.64
$104.40
Incyte
Incyte INCY
Director
Holding Value $1.39M 13,341 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$646k 9,216 shares
$70.07
$104.40
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Director
Holding Value $702k 13,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$501k 13,000 shares
$38.57
$53.99
Incyte
Incyte INCY
Director
Holding Value $1.31M 12,517 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$920k 15,347 shares
$59.94
$104.40
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Director
Holding Value $702k 13,000 shares
Last Trade
May 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$703k 13,000 shares
$54.06
$53.99
Incyte
Incyte INCY
Director
Holding Value $1.18M 11,294 shares
Last Trade
Jun 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$848k 13,799 shares
$61.44
$104.40
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Director
Holding Value $702k 13,000 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$814k 13,000 shares
$62.59
$53.99
Incyte
Incyte INCY
Director
Holding Value $953k 9,124 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.4M 20,392 shares
$68.55
$104.40
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Director
Holding Value $648k 12,000 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$860k 12,000 shares
$71.70
$53.99
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Director
Holding Value $540k 10,000 shares
Last Trade
Jun 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.24M 10,000 shares
$123.71
$53.99
Incyte
Incyte INCY
Director
Holding Value $836k 8,010 shares
Last Trade
May 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$826k 9,933 shares
$83.16
$104.40
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Director
Holding Value $810k 15,000 shares
Last Trade
Jun 11, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$896k 15,000 shares
$59.70
$53.99
Incyte
Incyte INCY
Director
Holding Value $1.1M 10,514 shares
Last Trade
May 26, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.16M 11,796 shares
$98.68
$104.40
Incyte
Incyte INCY
Director
Holding Value $134k 1,285 shares
Last Trade
Mar 26, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$93.9k 1,424 shares
$65.92
$104.40
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Director
Holding Value $1.62M 30,000 shares
Last Trade
Jun 11, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.31M 30,000 shares
$43.52
$53.99

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up